Investors might want to bet on Compass, Inc. (COMP), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based ...

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based ...

LONDON & NEW YORK, March 26, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the completion of recruitment in the COMP005 phase 3 ...

SINGAPORE, April 08, 2025 (GLOBE NEWSWIRE) -- Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced that Julian Wright, the Lim Chong Yah Professor in the Department ...

Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.

Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.

Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.

With the Nasdaq Composite in bear market territory, many stocks look like absolute bargains compared to their previous values ...

Metso has announced a realignment of its U.S. distributor network through the acquisition of Compass Equipment by ICM Solutions. This strategic m ...